"CAS 1005168-10-4,Asivatrep, World Biggest Manufacturer
CAS 1005168-10-4,Asivatrep, , EE 99.9%, CAS 1005168-10-4,Asivatrep, ,HPLC more than 99.5%, Impurity less than 0.1%, Water less than 0.1%, stock keep 10-50kg.
CAS 1005168-10-4,Asivatrep, stable novel crystalline or amorphous form both we have, CAS 1005168-10-4,Asivatrep, no any IP problem. CAS 1005168-10-4,Asivatrep, DMF filling, free sample of CAS 1005168-10-4,Asivatrep, .
EOS Med Chem have already carried out CAS 1005168-10-4,Asivatrep, batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For CAS 1005168-10-4,Asivatrep, , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is CAS 1005168-10-4,Asivatrep, Intermeidates list, most from GMP plant:
Asivatrep, CAS 1005168-10-4 Intermediate, 5509-65-9, stock 7.8kg, assay 98.9%, White powder.
Asivatrep, CAS 1005168-10-4 Intermediate, 141743-49-9, stock 1.7kg, assay 98.4%, White powder.
Asivatrep, CAS 1005168-10-4 Intermediate, 811799-69-6, stock 1.2kg, assay 98.7%, White powder.
Asivatrep, CAS 1005168-10-4 Intermediate, 956901-21-6, stock 5.5kg, assay 98.3%, White powder.
Asivatrep, CAS 1005168-10-4 Intermediate, 1005172-60-0, stock 5.3kg, assay 98.6%, White powder.
Asivatrep, CAS 1005168-10-4 Intermediate, 956901-22-7, stock 4.9kg, assay 98.9%, White powder.
Asivatrep, CAS 1005168-10-4 Intermediate, 956901-23-8, stock 2.1kg, assay 98.4%, White powder.
CAS 1005168-10-4,Asivatrep, HNMR, MASS, COA, MSDS we have.
CAS 1005168-10-4,Asivatrep, , free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com"






